These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 33017386)

  • 1. Origin, structural characteristics, prevention measures, diagnosis and potential drugs to prevent and COVID-19.
    Santos-Sánchez NF; Salas-Coronado R
    Medwave; 2020 Sep; 20(8):e8037. PubMed ID: 33017386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.
    Wiersinga WJ; Rhodes A; Cheng AC; Peacock SJ; Prescott HC
    JAMA; 2020 Aug; 324(8):782-793. PubMed ID: 32648899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology, diagnosis and treatment of COVID-19.
    Zhai P; Ding Y; Wu X; Long J; Zhong Y; Li Y
    Int J Antimicrob Agents; 2020 May; 55(5):105955. PubMed ID: 32234468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 diagnosis and management: a comprehensive review.
    Pascarella G; Strumia A; Piliego C; Bruno F; Del Buono R; Costa F; Scarlata S; Agrò FE
    J Intern Med; 2020 Aug; 288(2):192-206. PubMed ID: 32348588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outbreak of COVID-19: An emerging global pandemic threat.
    Peng M
    Biomed Pharmacother; 2020 Sep; 129():110499. PubMed ID: 32768974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent progress on the diagnosis of 2019 Novel Coronavirus.
    Li C; Ren L
    Transbound Emerg Dis; 2020 Jul; 67(4):1485-1491. PubMed ID: 32395897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The race against COVID-19.
    Nat Nanotechnol; 2020 Apr; 15(4):239-240. PubMed ID: 32303704
    [No Abstract]   [Full Text] [Related]  

  • 10. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020.
    Liu R; Han H; Liu F; Lv Z; Wu K; Liu Y; Feng Y; Zhu C
    Clin Chim Acta; 2020 Jun; 505():172-175. PubMed ID: 32156607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies.
    Sharma A; Tiwari S; Deb MK; Marty JL
    Int J Antimicrob Agents; 2020 Aug; 56(2):106054. PubMed ID: 32534188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19).
    Ahn DG; Shin HJ; Kim MH; Lee S; Kim HS; Myoung J; Kim BT; Kim SJ
    J Microbiol Biotechnol; 2020 Mar; 30(3):313-324. PubMed ID: 32238757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A reverse-transcription recombinase-aided amplification assay for the rapid detection of N gene of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2).
    Wu T; Ge Y; Zhao K; Zhu X; Chen Y; Wu B; Zhu F; Zhu B; Cui L
    Virology; 2020 Oct; 549():1-4. PubMed ID: 32758712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options.
    Chakraborty C; Sharma AR; Sharma G; Bhattacharya M; Lee SS
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):4016-4026. PubMed ID: 32329877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19: Main therapeutic options.
    Hachfi W; Ben Lasfar N
    Tunis Med; 2020 Apr; 98(4):299-303. PubMed ID: 32395792
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) co-infection with HIV: clinical case series analysis in North Central Nigeria.
    Akyala AI; Iwu CJ
    Pan Afr Med J; 2020; 37():47. PubMed ID: 33209174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical consideration and management of coronavirus disease 2019].
    Ma K; Chen T; Han MF; Guo W; Ning Q
    Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):222-228. PubMed ID: 32306656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics of SARS-CoV-2 and potential pharmacological treatment].
    Pawlik L; Śpiołek E; Fichna J; Tarasiuk A
    Postepy Biochem; 2020 May; 66(2):83-90. PubMed ID: 32700510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Four Molecular
    Zhen W; Manji R; Smith E; Berry GJ
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32341143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focus on the 2019 novel coronavirus (SARS-CoV-2).
    Wang M; Zhang N
    Future Microbiol; 2020 Jul; 15():905-918. PubMed ID: 32524843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.